
NorthEdge invests £25.5m in Fine Industries
NorthEdge Capital has invested £25.5m in Teesside-based Fine Industries, a manufacturer of fine chemicals.
The fresh funding will be used to increase capacity and came from NorthEdge's debut fund, which closed on £225m earlier this year.
Debt
Debt facilities were provided by HSBC and Yorkshire Bank.
Company
Fine Industries manufactures fine chemicals for the agriculture, pharmaceutical and speciality chemicals markets. Its clients include global blue chip companies. The company's products are exported primarily to Switzerland, Germany, the US, Brazil and Ireland.
The company was established in 1977 and employs 270 people in its Seal Sands chemical plant in Middlesbrough. Fine Industries reported a turnover of £40m for the year ending 30 September 2013.
The business underwent a management buyout from previous parent company Degussa in 2008.
People
The transaction saw NorthEdge backing managing director Crain Morgan. Brian Davidson joins the company as non-executive director. The deal was led by NorthEdge partner Ray Stenton, director James Hall and investment manager Tom Rowley. Stenton and Hall will both join the board of Fine Industries as non-executive directors.
Advisers
Equity – KPMG, Alex Hartley (Financial due diligence); Addleshaw Goddard, Yunus Seedat (Legal).
Company – PwC, Paul Mankin (Financial due diligence); Bond Dickinson, Nigel Williams (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater